EUVIMEDEUVIMED entdecken
Open Access

SLC38A3 deficiency reveals a critical role of blood-derived glutamine in brain development

Inna Radzishevsky, Lama Harb, Maali Odeh, Inon Maoz, Aseel Saeed, Ankita Lahkar, Bella Agranovich, Ifat Abramovich, Farrukh A Chaudhry, Avi Avital iD, Daniel J Liebl, Herman Wolosker

Brain · 03.08.2026 · 149 (8) · 2747-2759

DOI: 10.1093/brain/awaf473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 24.12.2025. Verfasst von Inna Radzishevsky und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Ruth and Bruce Rappaport Faculty of Medicine, Department of Biochemistry, Technion-Israel Institute of Technology, Haifa 3525433, Israel. Hauptthemen laut MEDLINE: Brain, Glutamine, Blood-Brain Barrier, Amino Acid Transport Systems. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Health, NINDS NIH HHS, Israel Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biallelic mutations in SLC38A3 lead to postnatal progressive microcephaly, epilepsy and intellectual disability. However, the underlying pathophysiology remains unknown. Here, we identified Slc38a3 expressed at the vascular endothelium as a critical glutamine transporter that mediates blood-to-brain influx of glutamine through the blood–brain barrier. Endothelial selective deletion of Slc38a3 (Slc38a3-cKO) lowered the influx of glutamine across the blood–brain barrier and decreased brain glutamine levels in mouse pups. This was associated with lower transfer of glutamine carbons to glutamate and GABA, suggesting impairment of the glutamine–glutamate/GABA metabolic cycle. Like individuals with mutations in SLC38A3, Slc38a3-cKO pups developed postnatal progressive microcephaly, in addition to behavioural impairments and morphological alterations in synapses. Approximately 30% of Slc38a3-cKO pups failed to thrive, exhibiting motor dysfunction and preweaning lethality. Glutamine deficiency in the Slc38a3-cKO hippocampus was associated with a slower tricarboxylic acid cycle and a seemingly adaptive increase in glycolysis rate. Glutamine supplementation replenished brain glutamine, prevented microcephaly and normalized motor behaviour in Slc38a3-cKO pups, indicating that brain glutamine deficiency is the primary cause of the phenotype. In contrast to the dogma that all glutamine is produced locally in the brain, our data show that Slc38a3 provides blood-derived glutamine for neurotransmitter synthesis, energy metabolism and synaptogenesis. Our findings suggest that SLC38A3 mutations cause a glutamine-related blood–brain barrier aminoacidopathy and developmental disorder, which might be amenable to glutamine supplementation therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainGlutamineBlood-Brain BarrierAmino Acid Transport SystemsAnimalsMiceMice, KnockoutMicrocephalyFemaleGlutamic AcidMale

Stichwörter der Autor:innen

SN1SNAT3amino acid transportersglutamatergic transmissionglutamine–glutamate/GABA cyclemicrocephaly

Substanzen

GlutamineGlutamic AcidAmino Acid Transport Systems

Autor:innen und Institutionen

  • The Ruth and Bruce Rappaport Faculty of Medicine, Department of Biochemistry, Technion-Israel Institute of Technology, Haifa 3525433, Israel.
  • Department of Occupational Therapy, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa 3103301, Israel.
  • The Ruth and Bruce Rappaport Faculty of Medicine, Laura and Isaac Perlmutter Metabolomics Center, Technion-Israel Institute of Technology, Haifa 3525433, Israel.
  • The Institute of Basic Medical Sciences, University of Oslo, Oslo 0317, Norway.
  • The Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

ORCID-Profile: Avi Avital

Förderung

  • National Institute of Health
  • NINDS NIH HHS
  • Israel Science Foundation
  • Rappaport Family Institute for Research in the Medical Sciences
  • Laura and Isaac Perlmutter Metabolomics Center
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Radzishevsky, I., Harb, L., Odeh, M., Maoz, I., Saeed, A., Lahkar, A., Agranovich, B., Abramovich, I., Chaudhry, F. A., Avital, A., Liebl, D. J., & Wolosker, H. (2026). SLC38A3 deficiency reveals a critical role of blood-derived glutamine in brain development. Brain, 149(8), 2747-2759. https://doi.org/10.1093/brain/awaf473

Vancouver

Radzishevsky I, Harb L, Odeh M, Maoz I, Saeed A, Lahkar A, et al. SLC38A3 deficiency reveals a critical role of blood-derived glutamine in brain development. Brain. 2026;149(8):2747-2759. doi:10.1093/brain/awaf473

BibTeX
@article{Radzishevsky2026,
  author = {Radzishevsky, Inna and Harb, Lama and Odeh, Maali and Maoz, Inon and Saeed, Aseel and Lahkar, Ankita and Agranovich, Bella and Abramovich, Ifat and Chaudhry, Farrukh A and Avital, Avi and Liebl, Daniel J and Wolosker, Herman},
  title = {SLC38A3 deficiency reveals a critical role of blood-derived glutamine in brain development},
  journal = {Brain},
  year = {2026},
  volume = {149},
  number = {8},
  pages = {2747--2759},
  doi = {10.1093/brain/awaf473}
}
Kostenlos starten →